RBM5 and Familial prostate cancer: Our research revealed that overexpression of RBM5 induced the apoptosis of prostate cancer PC-3 cells by promoting the mitochondrial apoptotic pathway, activating the caspase-9- and caspase-3-dependent apoptosis.